We track 13F filings from hedge funds and other notable investors for a variety of purposes.
Keep Reading →
March 15 - Hedge Funds
The nationwide banking holiday declared by incoming President Franklin D. Roosevelt could have ended in disaster.
Keep Reading →
March 15 - News
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 13 - News
The Motley Fool recently published its list of The 25 Best Companies in America and while Bristol-Myers Squibb Co.
Keep Reading →
March 12 - News
The Motley Fool recently whittled down 1,700 public companies to name its list of The 25 Best Companies in America. Merck & Co., Inc.
Keep Reading →
March 12 - News
If you asked the average person on the street if America is overpopulated and the birth rate is too high, you'd likely receive "Yes" as your answer.
Keep Reading →
March 11 - News
Earnings season is winding down, with most companies already having reported their quarterly results.
Keep Reading →
March 11 - News
The Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI) gained more than 300 points, or 2.18%, this week, and set a new record high in each of the past four days.
Keep Reading →
March 10 - News
One of my favorite Warren Buffett quotes is that it’s far better to buy a wonderful company trading at a fair price than a fair company trading at a wonderful price. While...
Keep Reading →
March 10 - News
It took more than five years, but the Dow Jones Industrial Average 2 Minute (Dow Jones Indices: .DJI) has officially surpassed its previous record.
Keep Reading →
March 8 - News
Gilead Sciences, Inc. (NASDAQ:GILD) is the world’s foremost biopharmaceutical company when it comes to combating deadly virus.
Keep Reading →
March 8 - News
A common trap many investors fall into is becoming overly confident in their views. This leads to wagering too much on a single outcome.
Keep Reading →
March 7 - News
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Keep Reading →
March 7 - News
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 7 - News
Eight months ago, Bayer and Johnson & Johnson (NYSE:JNJ) announced that the Food and Drug Administration had issued a complete response letter for their anticoagulant, Xarelto...
Keep Reading →
March 6 - News
Last year will long be remembered for its remarkable advances in the diagnosis and prevention of HIV; OraSure Technologies gained FDA approval for the first-ever at-home, over...
Keep Reading →
March 6 - News
Are we beating up too much on Eli Lilly & Co.
Keep Reading →
March 6 - News
We track 13F filings from hedge funds and other notable investors, which disclose many of their long equity positions as of the end of the previous quarter, for a variety of purposes...
Keep Reading →
March 6 - Hedge Funds
Investing in the health care sector isn't easy.
Keep Reading →
March 5 - News
It's official: With today's surge, the Dow Jones Industrial Average has hit a new all-time high.
Keep Reading →
March 5 - News
The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics, Inc. (NASDAQ:MYGN) .
Keep Reading →
March 5 - News
Do good things come in small packages for big pharma? Most of investors' attention is given to blockbuster drugs and drugs that have the potential to be blockbusters.
Keep Reading →
March 5 - News
Gilead Sciences, Inc.
Keep Reading →
March 4 - Insider Trading
Hello and welcome, readers. I’d like to issue an informal apology for the delay in writing in recent weeks.
Keep Reading →
March 4 - News
Investors are always trying to find the right balance between risk andreward.
Keep Reading →
March 4 - News
Celgene Corporation (NASDAQ:CELG) has good news -- and it has bad news.
Keep Reading →
March 4 - News
Mirror, mirror, on the wall, who's the frailest big pharma of all? The patent cliff has certainly taken its toll over the past couple of years, weakening several successful pharmaceutical...
Keep Reading →
March 1 - News
Fisher Asset Management, a fund managed by billionaire (and author and Forbes columnist) Ken Fisher, filed its 13F for the fourth quarter of last year in January.
Keep Reading →
March 1 - Hedge Funds
Celgene Corporation (NASDAQ:CELG) shareholders didn't have to wait long for good news in 2013. On Jan.
Keep Reading →
February 26 - News
Every investor can appreciate a stock that consistently beats the Street without getting ahead of its fundamentals and risking a meltdown.
Keep Reading →
February 26 - News
Are Bristol Myers Squibb Co. (NYSE:BMY) and Eli Lilly & Co.
Keep Reading →
February 25 - News
One of the aspects that makes investing so interesting is the enormous impact psychology has on results (and profits) people achieve (or don’t). What makes this so fascinating...
Keep Reading →
February 25 - News
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company ...
Keep Reading →
February 25 - Dividend Stocks
The Dow Jones Industrial Average finished strong last week, and eked out a closing price just above the 14,000 mark.
Keep Reading →
February 25 - News
Recently, Keryx Biopharmaceuticals (NASDAQ:KERX) achieved a new milestone as the company declared remarkable results from its Phase 3 trials of Zerenex.
Keep Reading →
February 25 - News
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a great way to gain a detailed and thorough perspective on a company and its...
Keep Reading →
February 23 - News
It's been a riveting week for investors. After starting the shortened week up by 54 points on Tuesday, the Dow Jones Industrial Average proceeded to crater.
Keep Reading →
February 22 - News
Although spin-off situations offered investors compelling investment opportunities most of the time, investors should study each situation quite carefully to determine its own...
Keep Reading →
February 22 - News
All throughout Wall Street we keep hearing about Amarin Corporation plc (ADR) (NASDAQ:AMRN) being bought out by some type of Big Pharma company in the future. It's all rumors...
Keep Reading →
February 22 - News
Merck & Co., Inc. (NYSE:MRK) has to more heavily rely on top selling pharmaceuticals now that Singulair's off patent.
Keep Reading →
February 22 - News
Even with the delay inherent in 13F filings (these filings disclose many of a hedge fund or other investor’s long equity positions at the end of a quarter, but are not released...
Keep Reading →
February 22 - Hedge Funds
Analysts wonder if other drug companies will follow in the footsteps of Abbott Laboratories (NYSE:ABT) and spinoff different parts of their business.
Keep Reading →
February 21 - News
Stock buybacks are generally considered a bullish signal on Wall Street.
Keep Reading →
February 21 - News
I am always on the hunt to pick up those stocks which the investment managers are betting upon aggressively.
Keep Reading →
February 21 - News
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Keep Reading →
February 20 - News
We spend more money on our pets than ever before. Fido pulls on our heartstrings and out pop our wallets.
Keep Reading →
February 20 - News
Neither company has a stellar track record when it comes to dividends.
Keep Reading →
February 19 - Dividend Stocks
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
Keep Reading →
February 19 - News